C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anandi Sheth, MD, MSc
Emory University
Principal Investigator - Clement S Adebamowo, ScD
University of Maryland SOM
Principal Investigator - Gregory Taylor, MD
University of Maryland SOM
Principal Investigator - Jennifer S Smith, PhD
University of North Carolina, Chapel Hill
Study Chair - Katie Mollan, PhD
University of North Carolina, Chapel Hill
Study Director - Kayla Denson
Frontier Science Foundation
Study Director - Laura Gaydos, PhD
Emory University
Study Director - Lisa Flowers, MD, MPH
Emory University
Principal Investigator - Lisa Rahangdale, MD, MPH
University of North Carolina, Chapel Hill
Study Chair - Michael Hudgens, PhD
University of North Carolina, Chapel Hill
Study Director - Nicole Freitag
Frontier Science Foundation
Study Director - Patrick Ryscavage, MD
University of Maryland SOM
Study Director - Sue Siminski
Frontier Science Foundation
Study Director - Vikrant Sahasrabuddhe, MBBS, MPH, DrPH
Division of Cancer Prevention (DCP), NCI
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University Som Division/department: Gynecology & Obstetrics
Atlanta, Georgia, United States
Anandi Sheth, MD, MScLisa Flowers, MD, MPH - University of Maryland School of Medicine Division of Family and Community Medicine
Baltimore, Maryland, United States
Clement Adebamowo, ScDGregory Taylor, MD
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2026
- Primary completion
- 28 Feb 2027
- Completion
- 31 May 2027
- Last update posted
- 5 Jun 2026
- Registered enrollment
- 3,500
- Registry id
- NCT07520188
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.